These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7318034)

  • 1. Synthesis of immunologically active muramyl dipeptide derivatives containing a quinonyl moiety via aminoacyl intermediates.
    Fukuda T; Kobayashi S; Yukimasa H; Imada I; Fujino M; Azuma I; Yamamura Y
    Chem Pharm Bull (Tokyo); 1981 Aug; 29(8):2215-21. PubMed ID: 7318034
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical synthesis and adjuvant activity of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) analogs 1, 2.
    Kamisango K; Saiki I; Tanio Y; Kobayashi S; Fukuda T; Sekikawa I; Azuma I; Yamamura Y
    Chem Pharm Bull (Tokyo); 1981 Jun; 29(6):1644-54. PubMed ID: 7296716
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel quinonyl derivatives of muramyl dipeptide possessing potent antitumor activity.
    Kobayashi S; Fukuda T; Imada I; Fujino M; Azuma I; Yamamura Y
    Chem Pharm Bull (Tokyo); 1979 Dec; 27(12):3193-6. PubMed ID: 540343
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of carbohydrate analogs (positional, configurational, and optical) of n-acetylmuramoyl-L-alanyl-D-isoglutamine, and their immunoadjuvant activities.
    Hasegawa A; Kaneda Y; Goh Y; Nishibori K; Kiso M; Azuma I
    Carbohydr Res; 1981 Aug; 94(2):143-63. PubMed ID: 7273036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apyrogenic, adjuvant-active N-acetylmuramyl-dipeptides.
    Lefrancier P; Derrien M; Jamet X; Choay J; Lederer E; Audibert F; Parant M; Parant F; Chedid L
    J Med Chem; 1982 Jan; 25(1):87-90. PubMed ID: 7086827
    [No Abstract]   [Full Text] [Related]  

  • 6. [Synthesis of N-acetyl-muramyl-dipeptide--an immunoadjuvant].
    Chen ZY; Chen LF; Gong XQ
    Yao Xue Xue Bao; 1982 Jun; 17(6):425-30. PubMed ID: 7148465
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and immunoadjuvant activities of muramoyl-L-alanyl-D-isoglutamine and some carbohydrate analogs.
    Kiso M; Kaneda Y; Okumura H; Hasegawa A; Azuma I; Yamamura Y
    Carbohydr Res; 1980 Feb; 79(1):C17-9. PubMed ID: 7357566
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and immunoadjuvant activity of N-[2-O-(2-acetamido- 1,2,3,5-tetradeoxy-1,5-imino-D-glucitol-3-yl)-D-lactoyl]- L-alanyl-D-isoglutamine.
    Ishida H; Kitagawa M; Kiso M; Hasegawa A; Azuma I
    Carbohydr Res; 1990 Dec; 208():267-72. PubMed ID: 2085813
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis of N-acetyl-6-amino- and -6-(acylamino)-6-deoxymuramoyl dipeptides, and their immunoadjuvant activities.
    Hasegawa A; Okumura H; Kiso M; Azuma I; Yamamura Y
    Carbohydr Res; 1980 Feb; 79(1):C20-3. PubMed ID: 7357567
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and immunoadjuvant activity of 2,2'-O-[2,2'-diacetamido-2,3,2',3'-tetradeoxy-6,6'-di-O-(2-tetradecyl- hexadecanoyl)-alpha,alpha'-trehalose-3,3'-diyl]bis(N-D-lactoyl-L-alanyl -D-isoglutamine).
    Ishida H; Imai Y; Kiso M; Hasegawa A; Sakurai T; Azuma I
    Carbohydr Res; 1989 Dec; 195(1):59-66. PubMed ID: 2636046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant and antitumor activities of quinonyl-N-acetylmuramyldipeptides.
    Azuma I; Yamawaki M; Uemiya M; Saiki I; Tanio Y; Kobayashi S; Fukuda T; Imada I; Yamamura Y
    Gan; 1979 Dec; 70(6):847-8. PubMed ID: 535688
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant activities of quinonyl-N-acetyl muramyl dipeptides in mice and guinea pigs.
    Saiki I; Tanio Y; Yamawaki M; Uemiya M; Kobayashi S; Fukuda T; Yukimasa H; Yamamura Y; Azuma I
    Infect Immun; 1981 Jan; 31(1):114-21. PubMed ID: 6971259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil.
    Carelli C; Audibert F; Chedid L
    Infect Immun; 1981 Jul; 33(1):312-4. PubMed ID: 7263069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A shortened synthesis of adjuvant dipeptide (MDP).
    Schwartzman SM; Ribi E
    Prep Biochem; 1980; 10(3):255-67. PubMed ID: 7413603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.
    Parant MA; Audibert FM; Chedid LA; Level MR; Lefrancier PL; Choay JP; Lederer E
    Infect Immun; 1980 Mar; 27(3):826-31. PubMed ID: 7380554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of some lipophilic derivatives of 1-thio-muramoyl-L-alanyl-D-isoglutamine.
    Hasegawa A; Seki E; Hioki Y; Kiso M; Azuma I
    Carbohydr Res; 1984 Aug; 131(1):61-9. PubMed ID: 6488202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemical synthesis and immunologic activities of the active unit of BCG-CWS].
    Saiki I; Azuma I
    Nihon Rinsho; 1981 Apr; 39(4):1861-7. PubMed ID: 7031298
    [No Abstract]   [Full Text] [Related]  

  • 18. Higher immunoadjuvant activities of N-acetyl-beta-D-glucosaminyl-(1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine in comparison with N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Tsujimoto M; Kinoshita F; Okunaga T; Kotani S; Kusumoto S; Yamamoto K; Shiba T
    Microbiol Immunol; 1979; 23(9):933-6. PubMed ID: 576117
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunostimulant activity in conformationally constrained analogues of MDP.
    Kundu B; Rizvi SY; Haq W; Saxena RP; Saxena KC; Mathru KB
    Indian J Biochem Biophys; 1987 Jun; 24(3):129-32. PubMed ID: 3428910
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent advances concerning the use of muramyl dipeptide derivatives as vaccine potentiators.
    Audibert F; Chedid L
    Prog Clin Biol Res; 1980; 47():325-38. PubMed ID: 7010376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.